Study of the gastrointestinal tumor progression during the COVID-19 epidemic in Wuhan
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Due to the restriction caused by the COVID?19 epidemic, the cancer community currently faces many difficulties1. First, tumor patients had to risk the chances of exposure when they went to the cancer clinic. Second, cancer treatment could predispose patients to more serious effects of COVID?19. Third, infection of COVID?19 after tumor surgeries could lead to higher levels of comorbidity2, 3. Thus, the surgeons and oncologists have to weigh the risk of COVID?19 infection against the magnitude of benefit of cancer treatments. Especially, along with the restoration of the medic order in the hospitals in Wuhan, the effects of those delayed treatments are now showing up in the following months
BJS (British Journal of Surgery) , article en libre accès, 2019